Massachusetts Financial Services’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$38.6M	Buy	339,742 +61,951	+22%	+$7.04M	0.01%	522
2025 Q1	$29.2M	Buy	277,791 +1,060	+0.4%	+$111K	0.01%	548
2024 Q4	$29.7M	Buy	+276,731	New	+$29.7M	0.01%	545